Open Access
RAIRO-Oper. Res.
Volume 56, Number 6, November-December 2022
Page(s) 4191 - 4227
Published online 21 December 2022
  • M. Ackermann, S.E. Verleden, M. Kuehnel, A. Haverich, T. Welte, F. Laenger, A. Vanstapel, C. Werlein, H. Stark, A. Tzankov and W.W. Li, Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N. Engl. J. Med. 383 (2020) 120–128. [CrossRef] [PubMed] [Google Scholar]
  • T. Ai, Z. Yang, H. Hou, C. Zhan, C. Chen, W. Lv, Q. Tao, Z. Sun and L. Xia, Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 case. Radiology 296 (2020) E32–E40. [CrossRef] [PubMed] [Google Scholar]
  • N.S. Aydin, E.B. Tirkolaee, Modelling and predicting the growth dynamics of COVID-19 pandemic: a comparative study including Turkey, J. Turkish Oper. Manage. 6 (2022) 943–954. [Google Scholar]
  • E. Babaee Tirkolaee and N.S. Aydın, A sustainable medical waste collection and transportation model for pandemics. Waste Manage. Res. 39 (2021) 34–44. [CrossRef] [PubMed] [Google Scholar]
  • J.J.V. Bavel, K. Baicker, P.S. Boggio, V. Capraro, A. Cichocka, M. Cikara, M.J. Crockett, A.J. Crum, K.M. Douglas, J.N. Druckman and J. Drury, Using social and behavioural science to support COVID-19 pandemic response. Nat. Human Behav. 4 (2020) 460–471. [CrossRef] [Google Scholar]
  • J.H. Beigel, K.M. Tomashek, L.E. Dodd, A.K. Mehta, B.S. Zingman, A.C. Kalil, E. Hohmann, H.Y. Chu, A. Luetkemeyer, S. Kline and D. Lopez de Castilla, Remdesivir for the treatment of COVID-19 – final report. N. Engl. J. Med. 383 (2020) 1813–1826. [CrossRef] [PubMed] [Google Scholar]
  • B. Bikdeli, M.V. Madhavan, D. Jimenez, T. Chuich, I. Dreyfus, E. Driggin, C.D. Nigoghossian, W. Ageno, M. Madjid, Y. Guo and L.V. Tang, COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J. Am. College Cardiol. 75 (2020) 2950–2973. [CrossRef] [Google Scholar]
  • B. Cao, Y. Wang, D. Wen, W. Liu, J. Wang, G. Fan, L. Ruan, B. Song, Y. Cai, M. Wei and X. Li, A trial of lopinavir–ritonavir in adults hospitalized with severe COVID-19. N. Engl. J. Med. 382 (2020) 1787–1799. [CrossRef] [PubMed] [Google Scholar]
  • J.F.W. Chan, S. Yuan, K.H. Kok, K.K.W. To, H. Chu, J. Yang, F. Xing, J. Liu, C.C.Y. Yip, R.W.S. Poon and H.W. Tsoi, A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 3952020 (2019) 514–523. [CrossRef] [PubMed] [Google Scholar]
  • N. Chen, M. Zhou, X. Dong, J. Qu, F. Gong, Y. Han, Y. Qiu, J. Wang, Y. Liu, Y. Wei and T. Yu, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(2020) 507–513. [CrossRef] [PubMed] [Google Scholar]
  • M. Chinazzi, J.T. Davis, M. Ajelli, C. Gioannini, M. Litvinova, S. Merler, A. Pastore y Piontti, K. Mu, L. Rossi, K. Sun and C. Viboud, The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science 368 (2020) 395–400. [NASA ADS] [CrossRef] [PubMed] [Google Scholar]
  • D.K. Chu, E.A. Akl, S. Duda, K. Solo, S. Yaacoub, H.J. Schünemann, A. El-Harakeh, A. Bognanni, T. Lotfi, M. Loeb and A. Hajizadeh, Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet 395 (2020) 1973–1987. [CrossRef] [PubMed] [Google Scholar]
  • E.J. Emanuel, G. Persad, R. Upshur, B. Thome, M. Parker, A. Glickman, C. Zhang, C. Boyle, M. Smith and J.P. Phillips, Fair allocation of scarce medical resources in the time of COVID-19. N. Engl. J. Med. 382 (2020) 2049–2055. [CrossRef] [PubMed] [Google Scholar]
  • P. Gautret, J. Lagier, P. Parola, L. Meddeb, M. Mailhe, B. Doudier, J. Courjon, V. Giordanengo, V.E. Vieira, H.T. Dupont and S. Honoré, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int. J. Antimicrob. Agents 56 (2020) 105949. [CrossRef] [Google Scholar]
  • A.H. Ghadir, H.R. Vandchali, M. Fallah and E.B. Tirkolaee, Evaluating the impacts of COVID-19 outbreak on supply chain risks by modified failure mode and effects analysis: a case study in an automotive company. Ann. Oper. Res. (2022) 1–31. DOI: 10.1007/s10479-022-04651-1. [Google Scholar]
  • D.E. Gordon, G.M. Jang, M. Bouhaddou, J. Xu, K. Obernier, K.M. White, M.J. O’Meara, V.V. Rezelj, J.Z. Guo, D.L. Swaney and T.A. Tummino, A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583 (2020) 459–468. [CrossRef] [PubMed] [Google Scholar]
  • G. Grasselli, A. Zangrillo, A. Zanella, M. Antonelli, L. Cabrini, A. Castelli, D. Cereda, A. Coluccello, G. Foti, R. Fumagalli and G. Iotti, Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA – J. Am. Med. Assoc. 323 (2020) 1574–1581. [CrossRef] [PubMed] [Google Scholar]
  • J. Grein, N. Ohmagari, D. Shin, G. Diaz, E. Asperges, A. Castagna, T. Feldt, G. Green, M.L. Green, F.X. Lescure and E. Nicastri, Compassionate use of remdesivir for patients with severe COVID-19. N. Engl. J. Med. 382 (2020) 2327–2336. [CrossRef] [PubMed] [Google Scholar]
  • W. Guan, Z. Ni, Y. Hu, W.H. Liang, C.Q. Ou, J.X. He, L. Liu, H. Shan, C.L. Lei, D.S. Hui and B. Du, Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382 (2020) 1708–1720. [CrossRef] [PubMed] [Google Scholar]
  • Y.R. Guo, Q.D. Cao, Z.S. Hong, Y.Y. Tan, S.D. Chen, H.J. Jin, K.S. Tan, D.Y. Wang and Y. Yan, The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil. Med. Res. 7 (2020) 1–10. [Google Scholar]
  • J. Helms, C. Tacquard, F. Severac, I. Leonard-Lorant, M. Ohana, X. Delabranche, H. Merdji, R. Clere-Jehl, M. Schenck, F. Fagot Gandet and S. Fafi-Kremer, High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med. 46 (2020) 1089–1098. [CrossRef] [PubMed] [Google Scholar]
  • M. Hoffmann, H. Kleine-Weber, S. Schroeder, N. Krüger, T. Herrler, S. Erichsen, T.S. Schiergens, G. Herrler, N.H. Wu, A. Nitsche and M.A. Müller, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181 (2020) 271–280. [CrossRef] [PubMed] [Google Scholar]
  • E.A. Holmes, R.C. O’Connor, V.H. Perry, I. Tracey, S. Wessely, L. Arseneault, C. Ballard, H. Christensen, R.C. Silver, I. Everall and T. Ford, Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry 7 (2020) 547–560. [CrossRef] [PubMed] [Google Scholar]
  • M.L. Holshue, C. DeBolt, S. Lindquist, K.H. Lofy, J. Wiesman, H. Bruce, C. Spitters, K. Ericson, S. Wilkerson, A. Tural and G. Diaz, First case of 2019 novel coronavirus in the United States. N. Engl. J. Med. 382 (2020) 929–936. [CrossRef] [PubMed] [Google Scholar]
  • P. Horby, W.S. Lim, J.R. Emberson, M. Mafham, J.L. Bell, L. Linsell, N. Staplin, C. Brightling, A. Ustianowski, E. Elmahi, B. Prudon, C. Green, T. Felton, D. Chadwick, K. Rege, C. Fegan, L.C. Chappell, S.N. Faust, T. Jaki, K. Jeffery, A. Montgomery, K. Rowan, E. Juszczak, J.K. Baillie, R. Haynes and M.J. Landray, Dexamethasone in hospitalized patients with Covid-19 – preliminary report. N Engl J Med 384 (2021) 693–704. [CrossRef] [PubMed] [Google Scholar]
  • M.M. Hossain, S.A. Sarwar, E.L.J. McKyer and P. Ma, Applications of artificial intelligence technologies in COVID-19 research: a bibliometric study. Preprints (2020). DOI: 10.20944/preprints202006.0161.v1. [Google Scholar]
  • C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu and Z. Cheng, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (2020) 497–506. [CrossRef] [PubMed] [Google Scholar]
  • Z. Jin, X. Du, Y. Xu, Y. Deng, M. Liu, Y. Zhao, B. Zhang, X. Li, L. Zhang, C. Peng and Y. Duan, Structure of MPRO from SARS-CoV-2 and discovery of its inhibitors. Nature 582 (2020) 289–293. [CrossRef] [PubMed] [Google Scholar]
  • G. Kampf, D. Todt, S. Pfaender and E. Steinmann, Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J. Hospital Infection 104 (2020) 246–251. [CrossRef] [Google Scholar]
  • M. Kappi, M.C. Sab, B.S. Biradar and V.T. Bagalkoti, Bibliometric study of world COVID-19 publication output. Shanlax Int. J. Arts Sci. Humanities 8 (2021) 86–95. [CrossRef] [Google Scholar]
  • S. Khalilpourazari, H.H. Doulabi, A.Ö. Çiftçioğlu and G.W. Weber, Gradient-based grey wolf optimizer with Gaussian walk: application in modelling and prediction of the COVID-19 pandemic. Expert Syst. App. 177 (2021) 114920. [CrossRef] [Google Scholar]
  • J. Lai, S. Ma, Y. Wang, Z. Cai, J. Hu, N. Wei, J. Wu, H. Du, T. Chen, R. Li, H. Tan, L. Kang, L. Yao, M. Huang, H. Wang, G. Wang, Z. Liu and S. Hu, Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw. Open 3 (2020) e203976. [CrossRef] [Google Scholar]
  • S.A. Lauer, K.H. Grantz, Q. Bi, F.K. Jones, Q. Zheng, H.R. Meredith, A.S. Azman, N.G. Reich and J. Lessler, The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann. Intern. Med. 172 (2020) 577–582. [CrossRef] [PubMed] [Google Scholar]
  • J.R. Lechien, C.M. Chiesa-Estomba, D.R. De Siati, M. Horoi, S.D. Le Bon, A. Rodriguez, D. Dequanter, S. Blecic, F. El Afia, L. Distinguin and Y. Chekkoury-Idrissi, Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur. Arch. Oto-Rhino-Laryngol. 277 (2020) 2251–2261. [CrossRef] [PubMed] [Google Scholar]
  • Y. Liu, A.A. Gayle, A. Wilder-Smith and J. Rocklöv, The reproductive number of COVID-19 is higher compared to SARS coronavirus. J. Travel Med. 27 (2020) 1–4. [Google Scholar]
  • R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu, W. Wang, H. Song, B. Huang, N. Zhu and Y. Bi, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395 (2020) 565–574. [CrossRef] [PubMed] [Google Scholar]
  • L. Mao, H. Jin, M. Wang, Y. Hu, S. Chen, Q. He, J. Chang, C. Hong, Y. Zhou, D. Wang and X. Miao, Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77 (2020) 683–690. [CrossRef] [PubMed] [Google Scholar]
  • A. Mondal and S.K. Roy, Multi-objective sustainable opened-and closed-loop supply chain under mixed uncertainty during COVID-19 pandemic situation, Comput. Ind. Eng. 159 (2021) 107453. [CrossRef] [Google Scholar]
  • M. Nicola, Z. Alsafi, C. Sohrabi, A. Kerwan, A. Al-Jabir, C. Iosifidis, M. Agha and R. Agha, The socio-economic implications of the coronavirus pandemic (COVID-19): a review. Int. J. Surgery 78 (2020) 185–193. [CrossRef] [Google Scholar]
  • F.P. Polack, S.J. Thomas, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, J.L. Perez, G.P. Marc, E.D. Moreira, C. Zerbini and R. Bailey, Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 383 (2020) 2603–2615. [CrossRef] [PubMed] [Google Scholar]
  • C. Qin, L. Zhou and Z. Hu, et al., Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 71 (2020) 762–768. [CrossRef] [PubMed] [Google Scholar]
  • R.P. Rajkumar, COVID-19 and mental health: a review of the existing literature. Asian J. Psychiatry 52 (2020) 102066. [CrossRef] [Google Scholar]
  • A. Remuzzi and G. Remuzzi, COVID-19 and italy: what next? Lancet 395 (2020) 1225–1228. [CrossRef] [PubMed] [Google Scholar]
  • S. Richardson, J.S. Hirsch, M. Narasimhan, J.M. Crawford, T. McGinn, K.W. Davidson, D.P. Barnaby, L.B. Becker, J.D. Chelico, S.L. Cohen and J. Cookingham, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA – J. Am. Med. Assoc. 323 (2020) 2052–2059. [CrossRef] [PubMed] [Google Scholar]
  • A.J. Rodriguez-Morales, J.A. Cardona-Ospina, E. Gutiérrez-Ocampo, E. Ocampo, R. Villamizar-Peña, Y. Holguin-Rivera, J.P. Escalera-Antezana, L.E. Alvarado-Arnez, D.K. Bonilla-Aldana, C. Franco-Paredes, A.F. Henao-Martinez and A. Paniz-Mondolfi, Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med. Infectious Dis. 34 (2020) 101623. [CrossRef] [Google Scholar]
  • H.A. Rothan and S.N. Byrareddy, The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmunity 109 (2020) 102433. [CrossRef] [Google Scholar]
  • T. Singhal, A review of coronavirus disease-2019 (COVID-19). Indian J. Pediatrics 87 (2020) 281–286. [CrossRef] [PubMed] [Google Scholar]
  • C. Sohrabi, Z. Alsafi, N. O’Neill, M. Khan, A. Kerwan, A. Al-Jabir, C. Iosifidis and R. Agha, World health organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19). Int. J. Surgery 76 (2020) 71–76. [CrossRef] [Google Scholar]
  • M. Su, S. Xu and J. Weng, A bibliometric study of COVID-19 researches in Web of Science. Pharmacol. Res. 169 (2021) 105664. [CrossRef] [Google Scholar]
  • M.Z. Tay, C.M. Poh, L. Rénia, P.A. MacAry and L.F.P. Ng, The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20 (2020) 363–374. [CrossRef] [PubMed] [Google Scholar]
  • E.B. Tirkolaee, A. Goli, P. Ghasemi and F. Goodarzian, Designing a sustainable closed-loop supply chain network of face masks during the COVID-19 pandemic: Pareto-based algorithms. J. Cleaner Prod. 333 (2022) 130056. [CrossRef] [Google Scholar]
  • N. Vasantha Raju and N.S. Harinarayana, Indian clinical trials on COVID-19: a review of clinical trials registry of India (CTRI) (2020). Available at SSRN 3674093. DOI: 10.2139/ssrn.3674093. [Google Scholar]
  • Y. Wan, J. Shang, R. Graham, R.S. Baric and F. Li, Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J. Virol. 94 (2020) e00127-20. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Y. Wang, D. Zhang, G. Du, R. Du, J. Zhao, Y. Jin, S. Fu, L. Gao, Z. Cheng, Q. Lu and Y. Hu, Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 395 (2020) 1569–1578. [CrossRef] [PubMed] [Google Scholar]
  • W.J. Wiersinga, A. Rhodes, A.C. Cheng, S.J. Peacock and H.C. Prescott, Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA – J. Am. Med. Assoc. 324 (2020) 782–793. [CrossRef] [PubMed] [Google Scholar]
  • R. Wölfel, V.M. Corman, W. Guggemos, M. Seilmaier, S. Zange, M.A. Müller, D. Niemeyer, T.C. Jones, P. Vollmar, C. Rothe and M. Hoelscher, Virological assessment of hospitalized patients with COVID-2019. Nature 581 (2020) 465–469. [CrossRef] [PubMed] [Google Scholar]
  • C. Wu, X. Chen, Y. Cai, X. Zhou, S. Xu, H. Huang, L. Zhang, X. Zhou, C. Du, Y. Zhang and J. Song, Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Med. 1802020 (2019) 934–943. [CrossRef] [PubMed] [Google Scholar]
  • F. Wu, S. Zhao, B. Yu, Y.M. Chen, W. Wang, Z.G. Song, Y. Hu, Z.W. Tao, J.H. Tian, Y.Y. Pei and M.L. Yuan, A new coronavirus associated with human respiratory disease in China. Nature 579 (2020) 265–269. [CrossRef] [PubMed] [Google Scholar]
  • Z. Xu, L. Shi, Y. Wang, J. Zhang, L. Huang, C. Zhang, S. Liu, P. Zhao, H. Liu, L. Zhu and Y. Tai, Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respiratory Med. 8 (2020) 420–422. [Google Scholar]
  • R. Yan, Y. Zhang, Y. Li, L. Xia, Y. Guo and Q. Zhou, Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367 (2020) 1444–1448. [CrossRef] [PubMed] [Google Scholar]
  • L. Zhang, D. Lin, X. Sun, U. Curth, C. Drosten, L. Sauerhering, S. Becker, K. Rox and R. Hilgenfeld, Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved a-ketoamide inhibitors. Science 368 (2020) 409–412. [CrossRef] [PubMed] [Google Scholar]
  • F. Zhou, T. Yu, R. Du, G. Fan, Y. Liu, Z. Liu, J. Xiang, Y. Wang, B. Song, X. Gu and L. Guan, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395 (2020) 1054–1062. [CrossRef] [PubMed] [Google Scholar]
  • P. Zhou, X. Yang, X. Wang, B. Hu, L. Zhang, W. Zhang, H.R. Si, Y. Zhu, B. Li, C.L. Huang and H.D. Chen, A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579 (2020) 270–273. [CrossRef] [PubMed] [Google Scholar]
  • N. Zhu, D. Zhang, W. Wang, X. Li, B. Yang, J. Song, X. Zhao, B. Huang, W. Shi, R. Lu and P. Niu, A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382 (2020) 727–733. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.